On February 20, 2018, Monika Duszyńska performed at the conference organized by Medical Pro Events. She raised a topic of the rules of the interchangeability of biological medicines which raises a number of doctors’ and patients’ concerns, including whether the patient's consent is required to change the medicine, what factors should be taken into account [...]
On 5 February 2018, Monika Duszyńska attended a debate entitled "Experts: It is the doctor who should decide on the therapy" organized by the editors of Medexpress. The debate was also attended by Irena Rej, President of the Chamber of Commerce "Farmacja Polska", prof. Michał Nowicki, President of the Polish Nephrological Society and Monika Zientek, [...]
In January 2018, “Hematologia” journal published the position of PTOK (Polish Society of Clinical Oncology) on the introduction of national standards for the use of biological medicines. One of its co-authors is Monika Duszyńska, who drafted the legal part on biological medicines and the principles of their substitution. From this year, clinical oncologists will have [...]
In April 2017 the results of another legal ranking, Chambers&Partners Europe, an international legal ranking, were announced. In this year edition Monika Duszyńska, ranked there since 2014, in the category Lifesciences, was raised from Band III to Band II. Chambers&Partners justifies this rise with the following statement: Monika Duszyńska of Monika Duszyńska Kancelaria Adwokacka climbs [...]
On 27 March, 2017, Monika Duszyńska at the conference „Healthcare Provider 2017 - Key changes in the health care system” raised the issue of the hospital's responsibility for clinical effects of treatment in the context of treatment continuation and drug substitution (primarily biological drugs). Monika referred to patients' rights in terms of the choice of [...]
Our law firm has been recognized in the recent edition of Polityka Insight ranking of the Polish regulatory law firms, in the category of the pharmaceutical law. Polityka Insight ranking is the first ranking in Poland taking into account quality data; its results come from research data obtained from the companies from determined sectors and [...]
On 2 and 28 February 2017, in Warsaw, Monika Duszyńska spoke at the following conferences: "Changes on the market of medical devices - new laws " and "Drug Reimbursement - amendment to the law - news". Monika Duszyńska talked about the planned legislative changes with regard to the rules for reimbursement of medical devices.
On 5 December 2016 Monika Duszyńska attended an expert’s debate on health and national security, organized by Polish Union of Oncology together with the Institute of Political Sciences of the Polish Academy of Sciences. Monika took part in the session entitled "Social solidarity as a proof of the responsibility of mature societies of the Old [...]
On 22 November 2016 Monika Duszyńska attended a debate entitled ‘Reimbursement Act - Directions of Change’, which took place at the 2nd Conference on drug policy organised by ‘Puls Medycyny’ magazine. The event was devoted to the draft amendments to the Reimbursement Act, which were under public consultations.
Monika Duszyńska on 10 June 2016 attended a meeting of patients with journalists, organised by the Polish Coalition of Oncology Patients. The meeting was dedicated to patients’ activities in parliamentary committees, and organisational changes in oncology. Monika spoke about the new regulation on an emergency access to medical technologies that replaced the former custom chemotherapy.
